AI assistant
Savills PLC Remuneration Information 2022
4850_def-14a_2022-05-26_474c2a97-3629-49b8-b16d-d2183af9e5cd.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 9801M
Savills PLC
26 May 2022
SAVILLS PLC (THE "COMPANY")
TRANSACTION IN SHARES BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)
Vesting of Share Awards
On 26 May 2022, ordinary shares of the Company have been allotted to Directors and PDMRs of the Company as follows in satisfaction of the partial vesting of Awards made on 22 May 2017 under the Performance Share Plan:-
| Director / PDMR | Number of Shares Transferred | Number of Shares Disposed | Shareholding following this notification | Shareholding as a % of issued share capital | Beneficial interest under the Performance Share Plan following this notification |
| Mark Ridley (Director) | 26,830 | 26,830 | 231,854 | 0.16 | 242,453 |
| Simon Shaw (Director) | 26,830 | 26,830 | 182,579 | 0.13 | 188,176 |
| Chris Lee (PDMR) | 7,985 | 7,985 | 119,000 | 0.08 | 95,690 |
The share price on disposal of all shares was £10.952661 per share.
The balance of the Awards made on 22 May 2017 have lapsed.
On 25 May 2022 the grant of an award has been made under The Schedule to The Savills Deferred Share Plan to a PDMR based in the United States of America as follows:-
| PDMR | Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 25 May 2022 | Resulting beneficial interest under the Savills Deferred Share Plan |
| David Lipson | 25,847 | 127,017 |
20% of the above award will vest on 18 April 2023, being the anniversary of the programme's original inception, and then 20% on each of the subsequent four anniversaries of that date subject to continued employment and satisfaction of performance criteria relating to gross billings.
The award is subject to rolled-up dividend shares whereby the number of shares awarded shall be increased on the vesting dates to reflect final and interim dividends declared during the Deferred Periods.
The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.
| 1. | Details of the Director/ PDMR | ||
| (a) | Name | 1. Mark Ridley 2. Simon Shaw 3. Chris Lee 4. David Lipson |
|
| 2. | Reason for the notification | ||
| (a) | Position/ status | 1. Group Chief Executive/ Director 2. Group Chief Financial Officer/ Director 3. Group Legal Director and Company Secretary/ PDMR 4. President - Savills North America/ PDMR |
|
| (b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer | ||
| (a) | Name | Savills plc | |
| (b) | LEI | 213800WXICGMBWHTA933 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| (a) | Description of the Financial Instrument | Savills plc Ordinary Shares of 2.5p each | |
| (b) | Identification code of the Financial Instrument | GB00B135BJ46 | |
| (c) | Nature of the transaction | Vesting of awards under the Company's Performance Share Plan and sale of resultant shares for persons 1 - 3 | |
| (d) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Acquisition £0.025 per share |
1. 26,830 2. 26,830 3. 7,985 |
||
| Disposal £10.952661 per share |
1. 26,830 2. 26,830 3. 7,985 |
||
| (e) | Aggregated information - Aggregated volume - Price |
N/A | |
| (f) | Date of the transaction | 26 May 2022 | |
| (g) | Place of the transaction | London Stock Exchange (XLON) | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| (a) | Description of the Financial Instrument | Award over Savills plc Ordinary Shares in accordance with the Company's Deferred Share Plan | |
| (b) | Identification code of the Financial instrument | GB00B135BJ46 | |
| (c) | Nature of the transaction | Grant of an award over Ordinary Shares in accordance with the Company's Deferred Share Plan in respect of David Lipson | |
| (d) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £nil per share | 25,847 | ||
| (d) | Aggregated information - Aggregated volume - Price |
N/A | |
| (f) | Date of the transaction | 25 May 2022 | |
| (g) | Place of the transaction | Outside a trading venue |
Name of contact and telephone number for queries:
Chris Lee
Group Legal Director & Company Secretary
020 3107 5444
26 May 2022
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHKZGZKDVKGZZM